explore -WSS

explore

author：leisure time 2025-09-29 01:38:50 - browse：68

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Curing rare childhood diseases will falter unless Congress steps up

WSS

Lung cancer is America's deadliest cancer. Yet so few get screened

Study: Why relieving medical debt did not improve financial outcomes

Congress must give Medicare recipients genetic counseling access

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Medical device trials still don't enroll enough women, study finds

hotspot

explore

leisure time

How one medical school became remarkably diverse

ProMED sees offers of support, but its future remains unclear

Cancer drug shortages should be causing more outrage

New report analyzes digital physical therapy solutions' effectiveness

Affirmative action in medical school literally saved lives

Study: Why relieving medical debt did not improve financial outcomes

DIEP, the 'gold standard' of breast reconstruction, is under threat

Deposition: Sackler embraced plan to conceal OxyContin’s strength

At least 13 dead in Texas as scorching temps continue

Stephen Quake on the Chan Zuckerberg quest to conquer disease

focus

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

'Essentially witchcraft:' A former naturopath takes on the field

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Evacuations in place as 3 wildfires burn in eastern Washington state

leisure time

Wikipedia

knowledge

knowledge